Alternative Medicine

Biography

Xandria Williams. PhD, MSc, DIC, ARCS, ND, DBM, gained degrees in Chemistry from Imperial College, London, and Otago University, New Zealand. She studied Biochemistry and did a full Naturopathic Diploma in Australia. She has been Head of the Nutrition and Biochemistry Departments in, and lectured extensively at, several Naturopathic, Nutritional, Chiropractic and Osteopathic Colleges, both in Australia and England. She is the Director of the CanSurvive Education Centre (CSEC) and runs a one-year Advanced Cancer Care Course for practitioners and advanced students wishing to specialize in cancer support. She backs this up with tutoring and lecture sessions for students and practitioners looking for mentoring support. Her published works include over 400 articles and 22 books. For nearly 20 years her research focus has been on the scientific basis for the metabolic approaches to cancer prevention and care. Her recent books include ‘‘Vital Signs for Cancer’’, “Cancer Concerns’’, ‘‘Detecting Cancer’’ and ‘‘Liver Detox Plan’’.

Abstract

The somatic mutation theory of cancer has been the foundation of the unstructured medical approach to cancer for the last century or more. However, with this application being the go-to in terms of cancer treatment, the incidence of cancer has continued to increase. According to the World Health Organisation, the number of new cases is expected to rise to about 70% over the next two decades. The metabolic theory of cancer, a biochemical based approach, initiated nearly a century ago by Nobel Prize-winning Biochemist Dr. Otto Warburg.  It is gradually but steadily becoming increasingly accepted, by biochemists, alternative practitioners and many forward-thinking doctors. This approach has been used successfully for many years and is based on a thorough understanding of the way in which the cancer process starts, progresses, and can be reversed. This personalised approach is based on determining the correct diet and lifestyle considerations appropriate for the unique metabolic needs of each client, thus restoring homeostasis and promoting health. There are tests available that further help to guide our protocols. Our CA1 panel can detect developing cancer many years before there is a detectable tumour, and at a time when recovery is relatively simple, and based on restoring homoeostasis rather than any drastic antic-cancer protocol. It can also be used to monitor progress. Our CA2 panel provides information as to the characteristics of the individual’s specific cancer and behaviours. These results enable us to further plan and monitor an appropriate program. The programs protocols that evolve are safe, non-toxic, effective and personalised for each client and their unique metabolic needs.